Global Peripheral Vascular Devices Market Size By Type (Peripheral vascular stents, PTA balloon catheter), By Application (The treatment of peripheral blood vessels damaged, The treatment of periphera...

The Global Peripheral Vascular Devices Market was valued at USD 10.4 billion in 2023 and is projected to reach USD 18.1 billion by 2031, growing at a CAGR of 7.1% during the forecast period from 2023 to 2031. The rising prevalence of peripheral artery disease (PAD), increasing aging population, technological innovations in vascular intervention devices, and growing demand for minimally invasive procedures are key factors fueling market expansion. Additionally, increased awareness and screening programs for vascular diseases are driving early diagnosis and treatment, further bolstering the demand for peripheral vascular devices globally.

Drivers:

1. Rising Incidence of Peripheral Artery Disease (PAD):

An aging global population and a surge in risk factors such as diabetes, smoking, and hypertension have led to an increased prevalence of PAD, necessitating a greater demand for peripheral vascular devices for diagnosis and treatment.

2. Shift Towards Minimally Invasive Procedures:

Minimally invasive vascular procedures are gaining popularity due to reduced recovery times, lower complication rates, and enhanced patient outcomes. This trend supports the growth of devices such as angioplasty balloons, stents, and atherectomy systems.

3. Advancements in Device Technology:

Ongoing innovations, including drug-coated balloons, bioresorbable stents, and imaging-assisted catheters, are significantly enhancing procedural success rates and reducing restenosis, driving broader adoption.

Restraints:

1. High Cost of Advanced Devices and Procedures:

Advanced peripheral vascular devices can be expensive, limiting accessibility in low-income and rural regions. Reimbursement constraints in certain healthcare systems may also impede market growth.

2. Regulatory and Product Approval Challenges:

Stringent regulatory frameworks and the long timelines required for clinical trials and device approvals can delay product launches, especially in emerging markets.

Opportunity:

1. Growth Potential in Emerging Markets:

Rapid healthcare infrastructure development in regions such as Asia-Pacific and Latin America, combined with rising patient awareness, presents lucrative opportunities for market expansion.

2. Expansion of Televascular Diagnostics and Mobile Health (mHealth):

The integration of digital health technologies in vascular monitoring and diagnosis—particularly in remote or underserved areas—is creating new avenues for innovation and market penetration.

Market by System Type Insights:

Among the device categories, angioplasty balloons held the largest market share in 2023, primarily driven by their efficacy in restoring blood flow in occluded arteries. Stents, particularly drug-eluting variants, are expected to witness the highest growth due to their role in preventing restenosis and ensuring long-term vessel patency. Additionally, atherectomy devices are gaining traction in complex and calcified lesions, further diversifying the device landscape.

Market by End-use Insights:

Hospitals were the dominant end-user segment in 2023, accounting for over 50% of the market share. This dominance is attributed to the availability of advanced infrastructure and skilled vascular specialists. Ambulatory surgical centers (ASCs) are expected to grow rapidly due to their cost-effectiveness, shorter wait times, and the growing preference for outpatient vascular procedures.

Market by Regional Insights:

North America led the global market in 2023, backed by robust healthcare spending, early adoption of new technologies, and high PAD incidence rates. Asia-Pacific is poised to be the fastest-growing region, propelled by increasing healthcare access, government initiatives to combat cardiovascular diseases, and a growing aging population in countries such as China, India, and Japan.

Competitive Scenario:

Key players in the Global Peripheral Vascular Devices Market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Becton, Dickinson and Company (BD), Cook Medical, Cardinal Health, B. Braun Melsungen AG, Philips Healthcare, and iVascular. These companies are focusing on expanding their product portfolios through R&D, strategic collaborations, and acquisitions. For example:

In 2023, Abbott Laboratories launched a next-generation drug-coated balloon catheter aimed at complex peripheral interventions.

In 2024, Boston Scientific announced an acquisition of a vascular imaging startup to enhance precision-guided interventions.

In 2025, Medtronic expanded its global clinical trial program to evaluate a new class of bioresorbable vascular scaffolds.

Scope of Work – Global Peripheral Vascular Devices Market

Key Market Developments:

July 2023: Medtronic received FDA approval for its new peripheral drug-coated balloon catheter designed to reduce restenosis in femoropopliteal arteries.

May 2024: Terumo introduced a hybrid vascular intervention system integrating imaging and navigation support.

February 2025: Philips launched an AI-driven platform to assist in real-time decision-making during peripheral vascular interventions.

FAQs:

1) What is the current market size of the Global Peripheral Vascular Devices Market?

The market was valued at USD 10.4 billion in 2023.

2) What is the major growth driver of the Global Peripheral Vascular Devices Market?

The major driver is the rising incidence of peripheral artery disease (PAD) and increasing preference for minimally invasive vascular procedures.

3) Which is the largest region during the forecast period in the Global Peripheral Vascular Devices Market?

North America is the largest region, owing to advanced healthcare infrastructure and high disease prevalence.

4) Which segment accounted for the largest market share in the Global Peripheral Vascular Devices Market?

The angioplasty balloon segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Peripheral Vascular Devices Market?

Key players include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, and BD.